Avastin Wins FDA Approval For Colorectal Cancer Treatment
The U.S. Food and Drug Administration (FDA) has approved use of Roche's Avastin for patients with colorectal cancer that has gotten worse despite treatment with the medication. This new approval will permit patients who were already treated once with Avastin plus chemotherapy to be treated again with Avastin in combination with a different chemotherapy regimen...Abraxane Improves Survival Among Pancreatic Cancer Patients Antibiotic Resistance Now A Serious Threat, Warns Top Doctor
